Vancomicina en infusión continua en pacientes pediátricos críticos
Zylbersztajn, Brenda Lara; Chicco, Pamela; Vega, Laura; Centeno, Mónica; Filippini, Silvia; Ruvinsky, Silvina.
Arch. argent. pediatr
; 111(1): e31-e34, feb. 2013. graf
Artigo em Espanhol | BINACIS | ID: bin-131162
Documentos relacionados
Prospective validation of a model-informed precision dosing tool for vancomycin treatment in neonates.
The effect of neutropenia on the clinical pharmacokinetics of vancomycin in adults.
Optimisation of vancomycin exposure in neonates based on the best level of evidence.
Determining the optimal vancomycin daily dose for pediatrics: a meta-analysis.
Vancomycin levels are frequently subtherapeutic in critically ill patients: a prospective observational study.
Does oral vancomycin use necessitate therapeutic drug monitoring?
The effect of body mass index and creatinine clearance on serum trough concentration of vancomycin in adult patients.
Assessment of optimal initial dosing regimen with vancomycin pharmacokinetics model in very low birth weight neonates.
Prospective validation of a model-informed precision dosing tool for vancomycin in intensive care patients.
Therapeutic drug monitoring of vancomycin in surgical patients using a validated HPLC method.